Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis
Journal of Aerosol Medicine and Pulmonary Drug Delivery · 01.12.2022 · 35 (6) · 291-295
DOI: 10.1089/jamp.2022.0025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Aerosol Medicine and Pulmonary Drug Delivery, online erschienen am 13.12.2022. Verfasst von Alain Martin und 2 weiteren Autor:innen. Beteiligte Einrichtung: EmphyCorp/Cellular Sciences, Inc., Flemington, New Jersey, USA. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Rhinitis, Allergic, Seasonal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
As an anti-inflammatory and antioxidant, sodium pyruvate significantly reduces inflammatory cytokines and oxygen radicals such as interleukin (IL) IL-6, IL-8, Monocyte Chemoattractant Protein-1, and hydrogen peroxide. Thus, sodium pyruvate holds promise as a treatment for many respiratory diseases, including allergic rhinitis (AR). Novel treatments for AR are needed as current medications, including steroids, often fail to treat severe symptoms.
Methods
The data from five human clinical studies were analyzed to determine the effect of 20 mM sodium pyruvate nasal spray (N115) in patients with AR. Nasal inflammation scores were compared to a placebo control or a no-treatment baseline control. Three studies were open-labeled and two were appropriately blinded to both patients and clinicians using computer randomization of subjects.
Results
The intranasal administration of sodium pyruvate significantly improved nasal inflammation scores in all five clinical trials of patients with AR ( p < 0.0001 in all trials).
Conclusions
These results give credence to the overall ability of sodium pyruvate, administered by nasal spray, to treat inflammation of the nasal airways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- EmphyCorp/Cellular Sciences, Inc., Flemington, New Jersey, USA.
- Department of Biology, Missouri State University, Springfield, Missouri, USA.
ORCID-Profile: Christopher Lupfer
Zitieren
APA
Martin, A., Lupfer, C., & Amen, R. (2022). Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 35(6), 291-295. https://doi.org/10.1089/jamp.2022.0025
Vancouver
Martin A, Lupfer C, Amen R. Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2022;35(6):291-295. doi:10.1089/jamp.2022.0025
BibTeX
@article{Martin2022,
author = {Martin, Alain and Lupfer, Christopher and Amen, Ronald},
title = {Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis},
journal = {Journal of Aerosol Medicine and Pulmonary Drug Delivery},
year = {2022},
volume = {35},
number = {6},
pages = {291--295},
doi = {10.1089/jamp.2022.0025}
}
EUVIMED